Entrada Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Entrada Therapeutics generated cash of $139,803,000, which is more than the previous year. Cash used in financing activities reached the amount of $21,037,000 last year. Net change in cash is therefore $22,445,000.
Cash Flow
| 2019 | -10.80M | -630K | 38K |
|---|---|---|---|
| 2020 | -25.57M | -2.31M | 50.08M |
| 2021 | -50.86M | -4.58M | 307.46M |
| 2022 | -93.78M | -148.65M | 479K |
| 2023 | 139.80M | -138.39M | 21.03M |
TRDA Cash Flow Statement (2019 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 49.10M | 291.06M | 39.04M | 16.84M | 28.23M |
Operating activities | |||||
Net income | -6.68M | -94.61M | -51.15M | -26.52M | -5.1M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.84M | 1.89M | 1.11M | 326K | 104K |
Stock-based compensation expense | 13.11M | 9.89M | 2.52M | 325K | 294K |
| Deferred income tax benefit | 13.11M | 9.89M | 2.52M | 325K | 294K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -2.80M | 5.28M | -715K | 631K | 367K |
Cash generated by operating activities | 139.80M | -93.78M | -50.86M | -25.57M | -10.80M |
Investing activities | |||||
Purchases Of Investments | -407.20M | -221.97M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -5.61M | -2.88M | -4.58M | -2.32M | -630K |
Acquisitions Net | 0 | 145.76M | 0 | 7K | 0 |
Cash generated by investing activities | -138.39M | -148.65M | -4.58M | -2.31M | -630K |
Financing activities | |||||
Common Stock Issued | 19.40M | 479K | 190.69M | 50.08M | 38K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 284K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 21.03M | 479K | 307.46M | 50.08M | 38K |
Net Change In Cash | 22.44M | -241.95M | 252.01M | 22.20M | -11.39M |
Cash at end of period | 71.55M | 49.10M | 291.06M | 39.04M | 16.84M |
| Data source | Data source | Data source |